Oral oxybutynin chloride therapy in the management of hidradenitis suppurativa: A prospective study

J Eur Acad Dermatol Venereol. 2023 Jun;37(6):e744-e746. doi: 10.1111/jdv.18901. Epub 2023 Jan 31.

Authors

Elisa Molinelli¹, Giovanni Marco D'Agostino¹, Claudia Sapigni¹, Helena Gioacchini¹, Valerio Brisigotti¹, Giulio Rizzetto¹, Annamaria Offidani¹, Oriana Simonetti¹

Affiliation

¹ Dermatological Unit, Department of Clinical and Molecular Sciences, Polytechnic Marche University, Ancona, Italy.

PMID: 36682048
DOI: 10.1111/jdv.18901

No abstract available

Publication types

Letter

MeSH terms

Anti-Bacterial Agents
Hidradenitis Suppurativa* / drug therapy
Humans
Mandelic Acids / therapeutic use
Prospective Studies

Substances

oxybutynin
Mandelic Acids
Anti-Bacterial Agents